LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.45 | 27.76 | 250 | 5745 | 0.0435 | 0.3307 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.45 | 27.76 | 1997 | 5745 | 0.3476 | 0.7433 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.45 | 27.76 | 2502 | 5745 | 0.4355 | 0.7952 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.45 | 27.76 | 2516 | 5745 | 0.4379 | 0.7965 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.15 | 27.76 | 2041 | 5906 | 0.3455 | 0.7432 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.15 | 27.76 | 2083 | 5906 | 0.3527 | 0.7478 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.15 | 27.76 | 282 | 5906 | 0.0477 | 0.3496 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.15 | 27.76 | 2151 | 5906 | 0.3642 | 0.7551 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.15 | 27.76 | 2637 | 5906 | 0.4465 | 0.8019 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.15 | 27.76 | 2653 | 5906 | 0.4492 | 0.8034 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.85 | 27.76 | 2193 | 6062 | 0.3617 | 0.7547 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.85 | 27.76 | 2232 | 6062 | 0.3682 | 0.7587 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.85 | 27.76 | 318 | 6062 | 0.0525 | 0.3686 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.85 | 27.76 | 2241 | 6062 | 0.3696 | 0.7596 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.85 | 27.76 | 2813 | 6062 | 0.4640 | 0.8118 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.85 | 27.76 | 2825 | 6062 | 0.4660 | 0.8128 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.56 | 27.76 | 2157 | 6217 | 0.3469 | 0.7464 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.56 | 27.76 | 2195 | 6217 | 0.3531 | 0.7503 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.56 | 27.76 | 338 | 6217 | 0.0544 | 0.3773 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.56 | 27.76 | 2329 | 6217 | 0.3746 | 0.7636 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.56 | 27.76 | 2935 | 6217 | 0.4721 | 0.8167 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.56 | 27.76 | 2955 | 6217 | 0.4753 | 0.8183 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.26 | 27.76 | 2377 | 6465 | 0.3676 | 0.7610 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.26 | 27.76 | 2417 | 6465 | 0.3738 | 0.7648 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.26 | 27.76 | 350 | 6465 | 0.0541 | 0.3803 | MN20160318_Q01 | F14 |